Screening the yeast genome for energetic metabolism pathways involved in a phenotypic response to the anti-cancer agent 3-bromopyruvate

Oncotarget

Volumn 7, Issue 9, 2016, Pages 10153-10173

  Lis, Paweł ^a   Jurkiewicz, Paweł ^a   Cal Bakowska, Magdalena ^a   Ko, Young H ^b   Pedersen, Peter L ^c   Goffeau, Andre ^d   Ułaszewski, Stanisław ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b UM BioPark   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

3 bromopyruvate (3 BP); Energetic metabolism; Genomic screen; Saccharomyces cerevisiae; Whi2

Indexed keywords

3 BROMOPYRUVATE; ANTINEOPLASTIC AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTATHIONE; PENTOSE PHOSPHATE; PHOSPHATASE; RAS PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG; WHI2P PHOSPHATASE; BROMOPYRUVATE; ENZYME INHIBITOR; PYRUVIC ACID DERIVATIVE; SACCHAROMYCES CEREVISIAE PROTEIN; WHI2 PROTEIN, S CEREVISIAE;

ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG ACTIVITY; DRUG RESPONSE; DRUG SENSITIVITY; FUNGAL GENOME; FUNGAL STRAIN; GENE DELETION; MITOCHONDRIAL RESPIRATION; MITOPHAGY; MUTANT; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; SCREENING; TOXICITY; YEAST CELL; BIOSYNTHESIS; DRUG EFFECTS; ENERGY METABOLISM; GENETICS; GLYCOLYSIS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MITOCHONDRION; PENTOSE PHOSPHATE CYCLE;

CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENERGY METABOLISM; ENZYME INHIBITORS; GENOME, FUNGAL; GLYCOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; PENTOSE PHOSPHATE PATHWAY; PYRUVATES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84961576984     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7174     Document Type: Article

References (77)

1. Khurana V, Lindquist S. Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast? Nat Rev Neurosci. 2010; 11:436-49.
2. Tosato V, Grüning NM, Breitenbach M, Arnak R, Ralser M, Bruschi CV. Warburg effect and translocation-induced genomic instability: two yeast models for cancer cells. Front Oncol. 2012; 2:212.
3. Goffeau A, Barrell BG, Bussey H, Davis RW, Dujon B, Feldmann H, Galibert F, Hoheisel JD, Jacq C, Johnston M, Louis EJ, Mewes HW, Murakami Y, Philippsen P, Tettelin H, Oliver SG. Life with 6000 genes. Science. 1996; 274:546, 563-7.
4. Jones GM, Stalker J, Humphray S, West A, Cox T, Rogers J, Dunham I, Prelich G. A systematic library for comprehensive overexpression screens in Saccharomyces cerevisiae. Nat Methods. 2008; 5:239-41.
5. Hartwell LH. Nobel Lecture. Yeast and cancer. Biosci Rep. 2002; 22:373-94.
6. Carmona-Gutierrez D, Ruckenstuhl C, Bauer MA, Eisenberg T, Büttner S, Madeo F. Cell death in yeast: growing applications of a dying buddy. Cell Death Differ. 2010; 17:733-4.
7. Pereira C, Coutinho I, Soares J, Bessa C, Leão M, Saraiva L. New insights into cancer-related proteins provided by the yeast model. FEBS J. 2012; 279:697-712.
8. Hartwell LH. Yeast and cancer. Biosci Rep. 2004; 24:523-44.
9. Matuo R, Sousa FG, Soares DG, Bonatto D, Saffi J, Escargueil AE, Larsen AK, Henriques JA. Saccharomyces cerevisiae as a model system to study the response to anticancer agents. Cancer Chemother Pharmacol. 2012; 70:491-502.
10. Entian KD, Fröhlich KU, Mecke D. Regulation of enzymes and isoenzymes of carbohydrate metabolism in the yeast Saccharomyces cerevisiae. Biochim Biophys Acta. 1984; 799:181-6.
11. Boles E, Schulte F, Miosga T, Freidel K, Schlüter E, Zimmermann FK, Hollenberg CP, Heinisch JJ. Characterization of a glucose-repressed pyruvate kinase (Pyk2p) in Saccharomyces cerevisiae that is catalytically insensitive to fructose-1, 6-bisphosphate. J Bacteriol. 1997; 179:2987-93.
12. Diaz-Ruiz R, Uribe-Carvajal S, Devin A, Rigoulet M. Tumor cell energy metabolism and its common features with yeast metabolism. Biochim Biophys Acta. 2009;1796:252-65.
13. Gey U, Czupalla C, Hoflack B, Rödel G, Krause-Buchholz U. Yeast pyruvate dehydrogenase complex is regulated by a concerted activity of two kinases and two phosphatases. J Biol Chem. 2008; 283:9759-67.
14. Krause-Buchholz U, Gey U, Wünschmann J, Becker S, Rödel G. YIL042c and OR090c encode the kinase and phosphatase of the Saccharomyces cerevisiae pyruvate dehydrogenase complex. FEBS Lett. 2006; 580:2553-60.
15. Roy DJ, Dawes IW. Cloning and characterization of the gene encoding lipoamide dehydrogenase in Saccharomyces cerevisiae. J Gen Microbiol. 1987; 133:925-33.
16. Pallotta ML, Valenti D, Iacovino M, Passarella S. Two separate pathways for d-lactate oxidation by Saccharomyces cerevisiae mitochondria which differ in energy production and carrier involvement. Biochim Biophys Acta. 2004; 1608:104-13.
17. Hohmann S, Cederberg H. Autoregulation may control the expression of yeast pyruvate decarboxylase structural genes PDC1 and PDC5. Eur J Biochem. 1990; 188:615-21.
18. Boubekeur S, Bunoust O, Camougrand N, Castroviejo M, Rigoulet M, Guérin B. A mitochondrial pyruvate dehydrogenase bypass in the yeast Saccharomyces cerevisiae. J Biol Chem. 1999; 274:21044-8.
19. Van Urk H, Voll WS, Scheffers WA, Van Dijken JP. Transient-state analysis of metabolic fluxes in crabtree-positive and crabtree-negative yeasts. Appl Environ Microbiol. 1990; 56:281-7.
20. Pedersen PL, Mathupala S, Rempel A, Geschwind JF, Ko YH. Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta. 2002; 1555:14-20.
21. Geschwind JF, Georgiades CS, Ko YH, Pedersen PL. Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma. Expert Rev Anticancer Ther. 2004; 4:449-57.
22. Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, Pedersen PL. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun. 2004; 324:269-75.
23. Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol. 2009; 19:17-24.
24. Ganapathy-Kanniappan S, Kunjithapatham R, Geschwind JF. Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting. Anticancer Res. 2013;33:13-20.
25. Ihrlund LS, Hernlund E, Khan O, Shoshan MC. 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs. Mol Oncol. 2008; 2:94-101.
26. Lis P, Zarzycki M, Ko YH, Casal M, Pedersen PL, Goffeau A, Ulaszewski S. Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae. J Bioenerg Biomembr. 2012; 44:155-61.
27. Sadowska-Bartosz I, Bartosz G. The effect of 3-bromopyruvic acid on human erythrocyte antioxidant defense system. Cell Biol Int. 2013; 37:1285-90.
28. Queirós O, Preto A, Pacheco A, Pinheiro C, Azevedo-Silva J, Moreira R, Pedro M, Ko YH, Pedersen PL, Baltazar F, Casal M. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate. J Bioenerg Biomembr. 2012; 44:141-53.
29. Birsoy K, Wang T, Possemato R, Yilmaz OH, Koch CE, Chen WW, Hutchins AW, Gultekin Y, Peterson TR, Carette JE, Brummelkamp TR, Clish CB, Sabatini DM. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat Genet. 2013; 45:104-8.
30. Majkowska-Skrobek G, Augustyniak D, Lis P, Bartkowiak A, Gonchar M, Ko YH, Pedersen PL, Goffeau A, Ulaszewski S. Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapy. Anticancer Drugs. 2014; 25:673-82.
31. Sadowska-Bartosz I, Soszynski M, Ulaszewski S, Ko Y, Bartosz G. Transport of 3-bromopyruvate across the human erythrocyte membrane. Cell Mol Biol Lett. 2014; 19:201-214.
32. Dylag M, Lis P, Niedzwiecka K, Ko YH, Pedersen PL, Goffeau A, Ulaszewski S. 3-Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans. Biochem Biophys Res Commun. 2013; 434:322-7.
33. Reddi AR, Culotta VC. SOD1 integrates signals from oxygen and glucose to repress respiration. Cell. 2013; 152:224-35.
34. Pasula S, Chakraborty S, Choi JH, Kim JH. Role of casein kinase 1 in the glucose sensor-mediated signaling pathway in yeast. BMC Cell Biol. 2010; 7;11:17.
35. Radcliffe PA, Binley KM, Trevethick J, Hall M, Sudbery PE. Filamentous growth of the budding yeast Saccharomyces cerevisiae induced by overexpression of the WHI2 gene. Microbiology. 1997; 143:1867-76.
36. Leadsham JE, Miller K, Ayscough KR, Colombo S, Martegani E, Sudbery P, Gourlay CW. Whi2p links nutritional sensing to actin-dependent Ras-cAMP-PKA regulation and apoptosis in yeast. J Cell Sci. 2009; 122:706-15.
37. Kaida D, Yashiroda H, Toh-e A, Kikuchi Y. Yeast Whi2 and Psr1-phosphatase form a complex and regulate STREmediated gene expression. Genes Cells. 2002; 7:543-52.
38. Radcliffe PA, Trevethick J, Tyers M, Sudbery P. Deregulation of CLN1 and CLN2 in the Saccharomyces cerevisiae whi2 mutant. Yeast. 1997; 13:707-15.
39. Mendl N, Occhipinti A, Müller M, Wild P, Dikic I, Reichert AS. Mitophagy in yeast is independent of mitochondrial fission and requires the stress response gene WHI2. J Cell Sci. 2011; 124:1339-50.
40. Siniossoglou S, Hurt EC, Pelham HR. Psr1p/Psr2p, two plasma membrane phosphatases with an essential DXDX(T/V) motif required for sodium stress response in yeast. J Biol Chem. 2000; 275:19352-60.
41. Sadeh A, Movshovich N, Volokh M, Gheber L, Aharoni A. Fine-tuning of the Msn2/4-mediated yeast stress responses as revealed by systematic deletion of Msn2/4 partners. Mol Biol Cell. 2011; 22:3127-38.
42. Martínez-Pastor MT, Marchler G, Schüller C, Marchler-Bauer A, Ruis H, Estruch F. The Saccharomyces cerevisiae zinc finger proteins Msn2p and Msn4p are required for transcriptional induction through the stress response element (STRE). EMBO J. 1996; 15:2227-35.
43. Casal M, Paiva S, Andrade RP, Gancedo C, Leão C. The lactate-proton symport of Saccharomyces cerevisiae is encoded by JEN1. J Bacteriol. 1999; 181:2620-3.
44. Pedersen PL. 3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anticancer agent taken from labside to bedside: introduction to a special issue. J Bioenerg Biomembr. 2012; 44:1-6.
45. Guaragnella N, Zdralevic M, Lattanzio P, Marzulli D, Pracheil T, Liu Z, Passarella S, Marra E, Giannattasio S. Yeast growth in raffinose results in resistance to acetic-acid induced programmed cell death mostly due to the activation of the mitochondrial retrograde pathway. Biochim Biophys Acta. 2013; 1833:2765-2774.
46. Moye-Rowley WS. Retrograde regulation of multidrug resistance in Saccharomyces cerevisiae. Gene. 2005; 354:15-21.
47. Panwar SL, Moye-Rowley WS. Long chain base tolerance in Saccharomyces cerevisiae is induced by retrograde signals from the mitochondria. J Biol Chem. 2006; 281:6376-84.
48. Del Giudice L, Massardo DR, Pontieri P, Wolf K. Interaction between yeast mitochondrial and nuclear genomes: null alleles of RTG genes affect resistance to the alkaloid lycorine in rho0 petites of Saccharomyces cerevisiae. Gene. 2005; 354:9-14.
49. Epstein CB, Waddle JA, Hale W 4th, Davé V, Thornton J, Macatee TL, Garner HR, Butow RA. Genome-wide responses to mitochondrial dysfunction. Mol Biol Cell. 2001; 12:297-308.
50. Jitrapakdee S, Adina-Zada A, Besant PG, Surinya KH, Cleland WW, Wallace JC, Attwood PV. Differential regulation of the yeast isozymes of pyruvate carboxylase and the locus of action of acetyl CoA. Int J Biochem Cell Biol. 2007; 39:1211-23.
51. Rodríguez A, De La Cera T, Herrero P, Moreno F. The hexokinase 2 protein regulates the expression of the GLK1, HXK1 and HXK2 genes of Saccharomyces cerevisiae. Biochem J. 2001; 355:625-31.
52. Matsushika A, Goshima T, Fujii T, Inoue H, Sawayama S, Yano S. Characterization of non-oxidative transaldolase and transketolase enzymes in the pentose phosphate pathway with regard to xylose utilization by recombinant Saccharomyces cerevisiae. Enzyme Microb Technol. 2012; 51:16-25.
53. Grant CM. Metabolic reconfiguration is a regulated response to oxidative stress. J Biol. 2008; 7:1.
54. Slekar KH, Kosman DJ, Culotta VC. The yeast copper/zinc superoxide dismutase and the pentose phosphate pathway play overlapping roles in oxidative stress protection. J Biol Chem. 1996; 271:28831-6.
55. Gorsich SW, Dien BS, Nichols NN, Slininger PJ, Liu ZL, Skory CD. Tolerance to furfural-induced stress is associated with pentose phosphate pathway genes ZWF1, GND1, RPE1, and TKL1 in Saccharomyces cerevisiae. Appl Microbiol Biotechnol. 2006; 71:339-49.
56. Mollapour M, Fong D, Balakrishnan K, Harris N, Thompson S, Schüller C, Kuchler K, Piper PW. Screening the yeast deletant mutant collection for hypersensitivity and hyper-resistance to sorbate, a weak organic acid food preservative. Yeast. 2004; 21:927-46.
57. Lloyd D, James CJ, Maitra PK. Mutations in phosphofructokinases alter the control characteristics of glycolysis in vivo in Saccharomyces cerevisiae. Yeast. 1992; 8:291-301.
58. Kitanovic A, Wölfl S. Fructose-1, 6-bisphosphatase mediates cellular responses to DNA damage and aging in Saccharomyces cerevisiae. Mutat Res. 2006; 594:135-47.
59. Palmieri L, Vozza A, Agrimi G, De Marco V, Runswick MJ, Palmieri F, Walker JE. Identification of the yeast mitochondrial transporter for oxaloacetate and sulfate. J Biol Chem. 1999; 274:22184-90.
60. Repetto B, Tzagoloff A. Structure and regulation of KGD1, the structural gene for yeast alpha-ketoglutarate dehydrogenase. Mol Cell Biol. 1989; 9:2695-705.
61. Graybill ER, Rouhier MF, Kirby CE, Hawes JW. Functional comparison of citrate synthase isoforms from S. cerevisiae. Arch Biochem Biophys. 2007; 465:26-37.
62. Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, Chen YC, Cox JE, Cardon CM, Van Vranken JG, Dephoure N, Redin C, Boudina S, Gygi SP, Brivet M, Thummel CS, Rutter J. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science. 2012; 337:96-100.
63. El Sayed SM, Mahmoud AA, El Sawy SA, Abdelaal EA, Fouad AM, Yousif RS, Hashim MS, Hemdan SB, Kadry ZM, Abdelmoaty MA, Gabr AG, Omran FM, Nabo MM, Ahmed NS. Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (Anticancer effects of 3-bromopyruvate through antagonizing Warburg effect). Med Hypotheses. 2013; doi:pii:S0306-9877(13)00423-4.10.1016/j.mehy.2013.08.024. [Epub ahead of print].
64. Broach JR. Nutritional control of growth and development in yeast. Genetics. 2012; 192:73-105.
65. Turcotte B, Liang XB, Robert F, Soontorngun N. Transcriptional regulation of nonfermentable carbon utilization in budding yeast. FEMS Yeast Res. 2010; 10:2-13.
66. Kim JH, Roy A, Jouandot D 2nd, Cho KH. The glucose signaling network in yeast. Biochim Biophys Acta. 2013; 1830:5204-10.
67. Dihazi H, Kessler R, Eschrich K. Glucose-induced stimulation of the Ras-cAMP pathway in yeast leads to multiple phosphorylations and activation of 6-phosphofructo-2-kinase. Biochemistry. 2003; 42:6275-82.
68. Portela P, Moreno S, Rossi S. Characterization of yeast pyruvate kinase 1 as a protein kinase A substrate, and specificity of the phosphorylation site sequence in the whole protein. Biochem J. 2006; 396:117-26.
69. Paiva S, Vieira N, Nondier I, Haguenauer-Tsapis R, Casal M, Urban-Grimal D. Glucose-induced ubiquitylation and endocytosis of the yeast Jen1 transporter: role of lysine 63-linked ubiquitin chains. J Biol Chem. 2009; 284:19228-36.
70. Thomas BJ, Rothstein R. Elevated recombination rates in transcriptionally active DNA. Cell. 1989; 56, 619-630.
71. Kaiser C, Michaeli S, Mitchel A. Methods in yeast genetics. A Cold Spring Harbor Laboratory Course Manual. 1994. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, N.Y.
72. Bonneaud N, Ozier-Kalogeropoulos O, Li GY, Labouesse M, Minvielle-Sebastia L, Lacroute F. A family of low and high copy replicative, integrative and single-stranded S. cerevisiae/E. coli shuttle vectors. Yeast. 1991; 7:609-15.
73. Longtine MS, McKenzie A 3rd, Demarini DJ, Shah NG, Wach A, Brachat A, Philippsen P, Pringle JR. Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast. 1998; 14:953-61.
74. Sambrook J, Russel D.W. Molecular cloning: a laboratory manual. 3rd ed. 2001. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
75. Slonimski P.P., Perodin G., Groft J.H. Biochem. Biophys. Res. Comm. 330, 232, 1968.
76. Gietz RD, Schiestl RH. High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc. 2007; 2:31-4.
77. Wach A, Brachat A, Pöhlmann R, Philippsen P. New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast. 1994; 10:1793-808.